AIM AND SCOPE
The Journal of Metabolic Disorders and Diabetes aims to serve as an international platform for the publication of high-quality research, clinical studies, and scholarly contributions related to metabolic disorders, diabetes, endocrinology, and therapeutic sciences. The journal is dedicated to advancing scientific understanding of metabolic diseases, improving diagnostic and preventive strategies, and promoting the development of innovative therapeutic approaches for diabetes and associated metabolic conditions. It seeks to bridge the gap between basic biomedical research and clinical practice by encouraging translational and interdisciplinary studies that contribute to improved patient care, disease prevention, and personalized medicine.
The journal also aims to foster collaboration among researchers, clinicians, academicians, nutritionists, endocrinologists, public health professionals, and healthcare providers worldwide. Emphasis is placed on scientific rigor, ethical research practices, and the dissemination of findings that have significant clinical, social, and global health impact in the field of metabolic disorders and diabetes management.
Scope of the Journal
The journal covers a broad range of topics related to metabolic disorders, diabetes, endocrinology, and therapeutic research. The primary areas of interest include, but are not limited to, the following:
Type 1 diabetes, Type 2 diabetes, gestational diabetes, juvenile diabetes, diabetes mellitus, insulin resistance, metabolic syndrome, obesity, overweight and obesity management, endocrine disorders, lipid metabolism disorders, dyslipidemia, hyperlipidemia, fatty liver disease, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), inherited metabolic disorders, inborn errors of metabolism, mitochondrial metabolic disorders, glycogen storage diseases, amino acid metabolism disorders, carbohydrate metabolism disorders, endocrine genetics, diabetic complications, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, diabetic cardiomyopathy, cardiovascular complications of diabetes, hypertension and metabolism, obesity-related disorders, nutritional deficiencies, micronutrient metabolism, hormonal regulation, insulin signaling pathways, pancreatic biology, beta-cell dysfunction, glucose metabolism, energy metabolism, metabolic pathways, endocrinology, neuroendocrinology, reproductive endocrinology, pediatric endocrinology, thyroid disorders, adrenal disorders, pituitary disorders, osteoporosis and bone metabolism, obesity surgery, bariatric surgery, lifestyle medicine, nutrition and dietetics, clinical nutrition, ketogenic diets, therapeutic nutrition, exercise physiology, diabetes prevention, public health approaches to diabetes, epidemiology of metabolic diseases, genetic predisposition to diabetes, pharmacogenomics in diabetes, biomarkers in metabolic disorders, molecular diagnostics, metabolomics, proteomics, transcriptomics, systems biology, computational biology, bioinformatics, artificial intelligence in metabolic research, machine learning in diabetes prediction, wearable health technologies, digital health, telemedicine, continuous glucose monitoring, insulin pumps, smart healthcare systems, drug discovery, drug development, antidiabetic medications, insulin therapy, incretin-based therapies, stem cell therapy, regenerative medicine, gene therapy, personalized medicine, precision medicine, clinical trials, translational medicine, rehabilitation in metabolic disorders, patient education, diabetes self-management, healthcare policies, community health, global diabetes burden, health disparities, quality of life studies, behavioral medicine, psychological aspects of diabetes, stress and metabolism, sleep disorders and metabolism, environmental factors in metabolic diseases, occupational health and metabolism, and emerging technologies in metabolic and endocrine research.
Types of Manuscripts
The journal accepts a variety of manuscript types including original research articles, review articles, systematic reviews, meta-analyses, case reports, case series, short communications, technical notes, clinical studies, perspectives, commentaries, and letters to the editor.
The topics listed above represent the primary areas of interest of the journal; however, the scope is not limited to these areas alone. The journal welcomes submissions from emerging, interdisciplinary, and innovative fields that contribute to the understanding, diagnosis, prevention, and treatment of metabolic disorders, diabetes, and related endocrine conditions.
Global Perspective and Inclusivity
The journal adopts a global perspective by encouraging submissions from researchers and clinicians across diverse geographic regions. Metabolic disorders and diabetes are among the leading global health challenges, with prevalence and disease burden varying significantly based on genetic, environmental, nutritional, and socio-economic factors.
By promoting international collaboration, the journal seeks to address global healthcare challenges and reduce disparities in access to diagnosis, prevention, and treatment of metabolic diseases. Studies highlighting regional trends, population-specific findings, healthcare strategies, and public health interventions are particularly encouraged.
Ethical, Legal, and Social Considerations
Research involving metabolic disorders and diabetes often raises important ethical, legal, and social issues. The journal recognizes the importance of responsible conduct in biomedical and clinical research and encourages scholarly work addressing patient rights, equitable healthcare access, informed consent, privacy, and ethical clinical practice.
Authors are expected to adhere to established ethical guidelines and ensure that their studies maintain scientific integrity, transparency, and respect for patient dignity and confidentiality.
Education and Knowledge Dissemination
The journal is committed to advancing education and knowledge dissemination in the field of metabolic disorders and diabetes. It aims to serve as a valuable educational resource for students, clinicians, researchers, healthcare professionals, and policymakers by publishing high-quality, informative, and impactful scientific content.
Educational reviews, clinical updates, and practical guidance articles that simplify complex metabolic concepts and support evidence-based clinical practice are highly encouraged.
Quality, Integrity, and Scientific Rigor
Maintaining high standards of quality, integrity, and scientific rigor is a core principle of the journal. All submissions are expected to demonstrate methodological soundness, originality, clarity, and ethical compliance.
The peer review process is designed to ensure unbiased and comprehensive evaluation of manuscripts. Authors are encouraged to present their findings transparently and accurately, thereby contributing to the credibility and reliability of scientific literature in metabolic and diabetes research.
Encouragement of Collaborative Research
The journal promotes collaborative and multidisciplinary research efforts involving endocrinologists, diabetologists, nutritionists, geneticists, molecular biologists, epidemiologists, pharmacologists, public health experts, and healthcare practitioners.
Collaborative studies that integrate clinical, translational, and technological approaches are highly encouraged, as they often lead to innovative solutions and improved understanding of complex metabolic diseases.
Adaptability to Advancing Science
The fields of metabolic disorders and diabetes research are rapidly evolving with continuous advancements in diagnostics, therapeutics, digital health technologies, and precision medicine. The journal remains adaptable to these developments by expanding its scope to include emerging areas of scientific and clinical research.
Authors are encouraged to explore novel concepts, innovative therapies, and advanced technologies that contribute to the evolving landscape of metabolic and endocrine sciences.
The Journal of Metabolic Disorders and Diabetes is committed to promoting excellence in metabolic and diabetes research by maintaining a broad, inclusive, and multidisciplinary scope. By encouraging high-quality scientific contributions from across the globe, the journal aims to support scientific advancement and improve healthcare outcomes for individuals affected by metabolic diseases and diabetes.
